Theravance Biopharma TBPH Compensation and benefits
Discontinued — last reported Q2 '23
Compensation and benefits at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.
The official record: Theravance Biopharma’s 10-Q, filed August 9, 2023, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Theravance Biopharma's compensation and benefits?
- Theravance Biopharma (TBPH) reported compensation and benefits of $6.26M in Q2 2023.
- How has Theravance Biopharma's compensation and benefits changed year-over-year?
- Theravance Biopharma's compensation and benefits decreased by 35.5% year-over-year, from $9.71M to $6.26M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.